NCT03165500

Brief Summary

The surgery for the extraction of the third molars is a procedure in Dentistry that generates a large picture of anxiety in the patient. One of the ways to try to soften this picture, are the professionals to use sedation. Thus, the objective of this study was to evaluate three sedation protocols, and to compare them with vital signs values, in order to obtain the sedation method with greater patients stability.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for early_phase_1

Timeline
Completed

Started Dec 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 23, 2015

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2017

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

May 17, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 24, 2017

Completed
Last Updated

May 24, 2017

Status Verified

May 1, 2017

Enrollment Period

12 months

First QC Date

May 17, 2017

Last Update Submit

May 22, 2017

Conditions

Keywords

ExodontiaSedationNitrous OxideBenzodiazepines

Outcome Measures

Primary Outcomes (1)

  • Assessment of blood pressure change

    Evaluated in anxious patients submitted to the exodontia of third molars, sedated with diazepam, midazolam and nitrous oxide.The investigator evaluated with auscultatory instrument.

    Immediately the arrival of the patient and before receiving sedation - 30 minutes after the patient receives oral sedation or 5 minutes after inhaled sedation- During the exodontia - 15 minutes after the end of surgery

Secondary Outcomes (2)

  • Assessment of heart rate change

    Immediately the arrival of the patient and before receiving sedation - 30 minutes after the patient receives oral sedation or 5 minutes after inhaled sedation- During the exodontia - 15 minutes after the end of surgery

  • Assessment of oxygen saturation change

    Immediately the arrival of the patient and before receiving sedation - 30 minutes after the patient receives oral sedation or 5 minutes after inhaled sedation- During the exodontia - 15 minutes after the end of surgery

Other Outcomes (2)

  • Retrograde amnesia

    Immediately the arrival of the patient and before receiving sedation - 30 minutes after the patient receives oral sedation or 5 minutes after inhaled sedation- 15 minutes after the end of surgery

  • Test of Trieger

    Measured 15 minutes after the end of surgery.]

Study Arms (3)

Diazepam

ACTIVE COMPARATOR

Sedation of the anxious patient with diazepam 5 mg for measuring vital signs (blood pressure, heart rate, oxygen saturation) in the pre, trans and postoperative periods of third molar extraction.

Drug: MidazolamDrug: Nitrous Oxide + Oxygen GasProcedure: Third molar extraction

Midazolam

ACTIVE COMPARATOR

Sedation of the anxious patient with midazolam 7.5 mg for measurement of vital signs (blood pressure, heart rate, oxygen saturation) in the pre, trans and postoperative periods of third molar extraction.

Drug: DiazepamDrug: Nitrous Oxide + Oxygen GasProcedure: Third molar extraction

Nitrous Oxide + Oxygen Gas

ACTIVE COMPARATOR

Inhaled sedation of the mixture of 40% of nitrous oxide and 60% of oxygen gas for measurement of vital signs (blood pressure, heart rate, oxygen saturation) in the pre, trans and postoperative periods of third molar extraction.

Drug: DiazepamDrug: MidazolamProcedure: Third molar extraction

Interventions

Patients' vital signs (blood pressure, heart rate and oxygen saturation) were measured and recorded after 30 minutes of oral sedation with diazepam 5mg, during the extraction procedure and 15 minutes after the extraction. After the surgical procedure of extraction, the patients remained in recovery in the same room, being the criteria of discharge realized, from the normality of the vital signs and the response to the verbal commands, with the patient responsive and lucid.

Also known as: Valium, Diazepam 5mg
MidazolamNitrous Oxide + Oxygen Gas

Patients' vital signs (blood pressure, heart rate, and oxygen saturation) were measured and recorded after 30 minutes of oral sedation with midazolam 7.5mg during the extraction procedure and 15 minutes after the extraction. After the surgical procedure of extraction, the patients remained in recovery in the same room, being the criteria of discharge realized, from the normality of the vital signs and the response to the verbal commands, with the patient responsive and lucid.

Also known as: Dormonid, Midazolam Oral Tablet
DiazepamNitrous Oxide + Oxygen Gas

Patients' vital signs (blood pressure, heart rate, and oxygen saturation) were measured and recorded after 30 minutes of sedation Inhalation with the mixture of 40% of nitrou oxide and 60% of oxygen, during the exodontia procedure and 15 minutes later. After the surgical procedure of extraction, the patients remained in recovery in the same room, being the discharge criteria performed, from the normality of the vital signs and the response to the verbal commands, with the patient responsive and lucid, and after the accomplishment of the test developed by Trieger et al.,(1971).

Also known as: Nitrous Oxide, Nitrous Oxide Inhalant Product
DiazepamMidazolam

Anxious patients in need of third molar extraction

Also known as: Third molar surgery
DiazepamMidazolamNitrous Oxide + Oxygen Gas

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy patients (ASA1), without surgical contra indications, requiring avulsion of the included third and / or semi-molar third molars,
  • Between the ages of 18 and 30,
  • Patients who agreed to voluntarily participate in the research, after knowing the risks and benefits, and signing the Informed Consent Form (TCLE).
  • Patients who presented moderate to high anxiety level in the questionnaire proposed by Corah in 1969.

You may not qualify if:

  • Patients with any systemic or local change that contra indicated the procedure,
  • Use of anti-inflammatories in the last 15 days,
  • Pericoronitis,
  • Patients who did not accept the Informed Consent Form (TCLE)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Joshi S, Ansari AS, Mazumdar S, Ansari S. A comparative study to assess the effect of oral alprazolam as premedication on vital parameters of patients during surgical removal of impacted mandibular third molars. Contemp Clin Dent. 2016 Oct-Dec;7(4):464-468. doi: 10.4103/0976-237X.194125.

  • Corah NL, Gale EN, Illig SJ. Assessment of a dental anxiety scale. J Am Dent Assoc. 1978 Nov;97(5):816-9. doi: 10.14219/jada.archive.1978.0394.

  • Khader R, Oreadi D, Finkelman M, Jarmoc M, Chaudhary S, Schumann R, Rosenberg M. A prospective randomized controlled trial of two different sedation sequences for third molar removal in adults. J Oral Maxillofac Surg. 2015 Feb;73(2):224-31. doi: 10.1016/j.joms.2014.08.033. Epub 2014 Sep 16.

MeSH Terms

Interventions

DiazepamMidazolamNitrous Oxide

Intervention Hierarchy (Ancestors)

BenzodiazepinonesBenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsNitrogen OxidesGasesInorganic ChemicalsNitrogen CompoundsOxidesOxygen Compounds

Study Officials

  • Michelle B Moraes, PHD

    ICT-UNESP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The investigadors selected 120 third molars , with the need for exodontia, in patients aged 18 to 30 years, ASA I, and with moderate to high anxiety level according to the Corah Dental Anxiety Scale (DAS). Patients were randomly assigned to three groups of 40 patients and submitted to the following anxiety control protocol: * Group I - Sedation with 5 mg oral Diazepam 30 minutes before surgery; * Group II - Sedation with 7.5 mg oral Midazolam 30 minutes before surgery; * Group III - Inhaled sedation with a mixture of 40% of nitrous oxide and 60% of oxygen (Using the Porter MXR 3000 Flowmeter (Parker Hannifin - Hatfield, PA, Philadelphia)) started 5 minutes before surgery.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Assistente Doutor - Departamento de Diagnóstico e Cirurgia - São Paulo State University (Unesp), Institute of Science and Technology, São José dos Campos, Brasil.

Study Record Dates

First Submitted

May 17, 2017

First Posted

May 24, 2017

Study Start

December 23, 2015

Primary Completion

December 20, 2016

Study Completion

May 4, 2017

Last Updated

May 24, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share